investorscraft@gmail.com

Intrinsic Value of FitLife Brands, Inc. (FTLF)

Previous Close$14.14
Intrinsic Value
Upside potential
Previous Close
$14.14

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

FitLife Brands, Inc. operates in the health and wellness sector, specializing in sports nutrition, weight management, and dietary supplements. The company generates revenue through the development, marketing, and distribution of proprietary and third-party branded products, primarily targeting fitness enthusiasts and health-conscious consumers. Its product portfolio includes performance-enhancing supplements, protein powders, and vitamins, sold through retail partners, e-commerce platforms, and direct-to-consumer channels. FitLife competes in a fragmented but growing market, leveraging its brand recognition and distribution network to maintain a niche position. The company focuses on innovation and strategic partnerships to differentiate itself from larger competitors, capitalizing on trends like personalized nutrition and functional foods. Its market positioning is reinforced by a loyal customer base and a reputation for quality, though it faces challenges from both established players and emerging brands in the highly competitive wellness industry.

Revenue Profitability And Efficiency

FitLife reported revenue of $64.5 million for the period, with net income of $9.0 million, reflecting a net margin of approximately 14%. The company generated $9.6 million in operating cash flow, demonstrating solid cash conversion efficiency. Capital expenditures were minimal at $10,000, indicating a capital-light business model. These metrics suggest effective cost management and operational efficiency, though further context on gross margins and SG&A expenses would provide deeper insight into profitability drivers.

Earnings Power And Capital Efficiency

Diluted EPS stood at $0.91, supported by disciplined capital allocation and a focus on high-margin products. The company’s ability to generate strong operating cash flow relative to net income highlights its earnings quality. With modest capital expenditures, FitLife appears to prioritize organic growth and working capital optimization, though its return on invested capital (ROIC) would offer a more comprehensive view of capital efficiency.

Balance Sheet And Financial Health

FitLife holds $4.5 million in cash and equivalents against $13.5 million in total debt, indicating a leveraged but manageable financial position. The absence of significant capital expenditures suggests limited near-term liquidity pressures. However, the debt-to-equity ratio and interest coverage metrics would provide a clearer assessment of financial health. The balance sheet appears adequate for its current scale, but flexibility for strategic investments may be constrained.

Growth Trends And Dividend Policy

Revenue growth trends are not provided, but the company’s net income and cash flow performance suggest stable profitability. FitLife does not currently pay dividends, reinvesting earnings back into the business. Future growth may hinge on product innovation, market expansion, or acquisitions, though the lack of dividend payments aligns with its focus on reinvestment for long-term value creation.

Valuation And Market Expectations

With a market capitalization not provided, valuation metrics such as P/E or EV/EBITDA cannot be calculated. The company’s $0.91 diluted EPS, if sustained, could attract investors seeking exposure to the health and wellness sector. Market expectations likely hinge on FitLife’s ability to maintain profitability and capture growth in the competitive supplement industry, though comparable company analysis would be needed for context.

Strategic Advantages And Outlook

FitLife’s strategic advantages include its niche brand positioning, efficient operations, and focus on high-margin products. The outlook depends on its ability to innovate and expand distribution amid intense competition. Macro trends favoring health and wellness could provide tailwinds, but execution risks and market saturation remain challenges. The company’s capital-light model and cash flow generation provide a foundation for resilience, though scalability may require further strategic initiatives.

Sources

Company filings (CIK: 0001374328), inferred financials for FY 2024

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount